These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 273888)
1. [Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)]. Marthé G; Misset JL; de Vassal F; Hayat M; Gouveia J; Machover D; Belpomme D; Schwarzenberg L; Ribaud P; Pico JL; Musset M; Jasmin C; de Luca L Nouv Presse Med; 1978 Feb; 7(7):525-8. PubMed ID: 273888 [TBL] [Abstract][Full Text] [Related]
2. Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine. Mathé G; Misset JL; De Vassal F; Gouveia J; Hayat M; Machover D; Belpomme D; Pico JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; De Luca L Cancer Treat Rep; 1978 May; 62(5):805-9. PubMed ID: 274996 [TBL] [Abstract][Full Text] [Related]
3. [Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)]. Maraninchi D; Gastaut JA; Tubiana N; Carcassonne Y Bull Cancer; 1981; 68(4):338-42. PubMed ID: 6947833 [TBL] [Abstract][Full Text] [Related]
4. Phase II trial of vindesine in patients with acute leukemia. Sklaroff RB; Arlin Z; Young CW Cancer Treat Rep; 1979; 63(11-12):2063-5. PubMed ID: 294307 [TBL] [Abstract][Full Text] [Related]
5. Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas. Bayssas M; Gouveia J; Ribaud P; Musset M; de Vassal F; Pico JL; de Luca L; Misset JL; Machover D; Belpomme D; Schwarzenberg L; Jasmin C; Hayat M; Mathé G Cancer Chemother Pharmacol; 1979; 2(4):247-55. PubMed ID: 287569 [TBL] [Abstract][Full Text] [Related]
6. [Phase II study of vindesine in hematological malignancies]. Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841 [TBL] [Abstract][Full Text] [Related]
7. Combination of vindesine and prednisone in malignant lymphoma and acute leukemia. Raich PC; Walker BK; Rogers JS; Subramanian VP; Fontana JA; Knost JA; Denning B Cancer Treat Rep; 1983 May; 67(5):485-7. PubMed ID: 6573959 [TBL] [Abstract][Full Text] [Related]
8. [Administration of vindesine sulfate for the treatment of malignant hematological tumors]. Ueda T; Masaoka T; Shibata H; Kubota Y; Saigo K; Kusakabe H; Takubo T; Nakamura H; Yoshitake J; Ishigami S Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103 [TBL] [Abstract][Full Text] [Related]
9. [Aclacinomycin-A in acute leukaemias and leukaemic non-Hodgkin lymphomas (author's transl)]. Mathé G; de Jager R; Hulhoven R; Delgado M; Machover D; Ribaud P; de Vassal F; Gil-Delgado M; Misset JL; Gouveia J; Jasmin C; Hayat M; Gastiaburu J; Schwarzenberg L Nouv Presse Med; 1982 Jan; 11(1):25-8. PubMed ID: 6949137 [TBL] [Abstract][Full Text] [Related]
11. [Phase II study of Vindesine in patients with hematological malignancy]. Sampi K; Honda T; Hayashi Y; Hattori M Gan To Kagaku Ryoho; 1983 Jun; 10(6):1536-7. PubMed ID: 6347082 [TBL] [Abstract][Full Text] [Related]
12. [Clinical experience with vinblastine and vincristine]. Cipriani D Cancro; 1968; 21():Suppl 6:185-9. PubMed ID: 5264169 [No Abstract] [Full Text] [Related]
13. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia. Frei E; Schabel FM; Goldin A Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419 [No Abstract] [Full Text] [Related]
14. [A randomized controlled study on vindesine and vincristine in combination with prednisolone in the treatment of adult acute lymphocytic leukemia and blastic crisis of chronic myeloid leukemia]. Gan To Kagaku Ryoho; 1983 Dec; 10(12):2500-8. PubMed ID: 6580840 [TBL] [Abstract][Full Text] [Related]
15. [Personal experience on the chemotherapy of leukemias and hematosarcomas]. Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537 [No Abstract] [Full Text] [Related]
16. m-AMSA: phase II trial in advanced lymphoma and leukemia. Case DC Am J Clin Oncol; 1984 Aug; 7(4):357-60. PubMed ID: 6588746 [TBL] [Abstract][Full Text] [Related]
17. [Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)]. Mathé G; Schwarzenberg L; Pouillart P; Weiner R; Oldham R; Jasmin C; Rosenfeld C; Hayat M; Schneider M; Amiel JL; Céoara B; Steresco-Musset M; de Vassal F Nouv Presse Med; 1974 Mar; 3(9):521-4. PubMed ID: 4595555 [No Abstract] [Full Text] [Related]
18. Leukemia and lymphoma. White LP Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229 [No Abstract] [Full Text] [Related]
19. [Polychemotherapy in non-hodgkin lymphoma with a modified MOPP scheme (author's transl)]. Tigges FJ; Schmülling RM; Hiller E; Waller HD; Wilms K Dtsch Med Wochenschr; 1977 Oct; 102(43):1537-41. PubMed ID: 334504 [TBL] [Abstract][Full Text] [Related]
20. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)]. Parlier Y; Gorin NC; Stachowiak J; Najman A; Duhamel G Sem Hop; 1981 Nov 8-25; 57(41-42):1685-90. PubMed ID: 6272402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]